New drug for lung sarcoidosis fails to complete trial
Disease control
Terminated
This study tested a drug called namilumab in 107 adults with chronic pulmonary sarcoidosis, a condition causing lung inflammation. Participants received either namilumab or a placebo to see if the drug could reduce the need for rescue treatments like steroids. The trial was termi…
Phase: PHASE2 • Sponsor: Kinevant Sciences GmbH • Aim: Disease control
Last updated May 22, 2026 13:52 UTC